Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Supha Pharmachem Ltd has informed BSE that the trading window for insiders will remain closed from 1st April 2026 until 48 hours after the declaration of its audited financial results (standalone and consolidated) for the quarter and year ending 31st March 2026. This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015. The company noted that the date of the board meeting to consider these results will be communicated separately. The filing was signed by the Whole Time Director on behalf of the suspended board, and the company remains under CIRP (Corporate Insolvency Resolution Process).
No direct impact on shareholders. This is a routine regulatory compliance announcement and does not signal any corporate action. Investors should note the upcoming audited results announcement, which may be material once released.